Pioglitazone in Acute Ischemic Stroke Trial

The requested reference [6eb8e15add4d149015c15ad761566baaeac35bdf] no longer exists in our database. It has been replaced by the current reference: [d561daa71dd42342aadcff9154494f05a73376de]

Authors
Category Primary study
JournalUMIN Clinical Trials Registry
Year 2008
INTERVENTION: Patients will be randomly selected to receive pioglitazone Patients will also be randomly selected to receive treatment with conventional therapy CONDITION: Ischemic stroke PRIMARY OUTCOME: NIH stroke scale score at 3 months SECONDARY OUTCOME: Recurrence of stroke and Cardiovascular event (cerebral hemorrhage, subarachnoid hemorrhage, myocardial infarction, angina pectoris, and ASO) within 3 months after starting treatment INCLUSION CRITERIA: 1.Admission within 7 days after the onset of ischemic stroke 2.Diabetes mellitus 3.cerebral thrombosis 4.NIHSS score 4‐15
Epistemonikos ID: 0f71d27f632a36630e0ded14356bd326b8b42a3a
First added on: Aug 21, 2024